| Product ID |
Product Name |
CAS# |
Purity |
| Y3287535 |
IL-17 modulator 3 |
2467731-88-8 |
99% |
| Y3263899 |
IRG1-IN-1 |
2407652-42-8 |
99% |
| Y3305218 |
ERAP2-IN-1 |
2420551-38-6 |
98% |
| Y3293206 |
PROTAC BRD9 Degrader-4 |
2633632-34-3 |
99% |
| Y3298102 |
Cinnamic acid-13C3 |
2734410-01-4 |
99% |
| Y3296124 |
DB1113 |
2769753-53-7 |
99% |
| Y3265081 |
PARP10/15-IN-3 |
2892064-88-7 |
99.98% |
| Y3266808 |
Fl-DIBO |
1407523-31-2 |
99.28% |
| Y3266299 |
Fipravirimat dihydrochloride |
2442512-14-1 |
95% |
| Y3118090 |
ISR-IN-1 |
1628478-15-8 |
95% |
| Y3286991 |
Autophagy inducer 3 |
2691054-63-2 |
99% |
| Y3289611 |
(S,S)-GNE 5729 |
2026636-06-4 |
99% |
| Y3287563 |
DSPE-N3 |
2839508-98-2 |
95% |
| Y3288381 |
ROCK2-IN-6 hydrochloride |
2762238-94-6 |
98% |
| Y3118094 |
3-(3-Methyl-1h-pyrazol-1-yl)benzaldehyde |
1340394-05-9 |
95% |
| Y3113754 |
Methyl 6-chloro-4-hydroxynicotinate |
1781900-26-2 |
98% |
| Y3272417 |
PBRM1-BD2-IN-8 |
2819989-75-6 |
99% |
| Y3266573 |
NOTA-AE105 |
1820563-84-5 |
99.37% |
| Y3266995 |
Mc-Alanyl-Alanyl-Asparagine-PAB-MMAE |
1638970-46-3 |
98.26% |
| Y3113779 |
6-Chloro-5-(trifluoromethyl)-2-pyridinecarboxamide |
1805633-34-4 |
98% |
| Y3113748 |
NLRP3/AIM2-IN-2 |
791840-86-3 |
98% |
| Y3294575 |
SIRT1-IN-2 |
2470969-89-0 |
98% |
| Y3268278 |
TIM-3-IN-1 |
2883237-04-3 |
99.15% |
| Y3308188 |
CrBKA |
2260810-48-6 |
98% |
| Y3288151 |
Antifungal agent 48 |
2142003-75-4 |
95% |
| Y3297261 |
MC4033 |
28532-21-0 |
99% |
| Y3271013 |
Glyoxalase I inhibitor 3 |
1415388-25-8 |
98% |
| Y3292830 |
R110 |
1985622-33-0 |
99% |
| Y3271571 |
NH2-methylpropanamide-Exatecan TFA |
1817857-35-4 |
99% |
| Y3297645 |
TH-Z93 |
2260887-09-8 |
99% |
| Y3118059 |
2-(4-(Dimethoxymethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
943239-68-7 |
97% |
| Y3295567 |
7-(Tert-butoxycarbonyl)-1-oxa-7-azaspiro[4.4]Nonane-2-carboxylic acid |
1268520-63-3 |
95% |
| Y3294322 |
PARP10/15-IN-1 |
2892065-01-7 |
95% |
| Y3310632 |
TP0597850 |
2642181-22-2 |
99% |
| Y3264955 |
DB-3-291 |
2769753-64-0 |
98% |
| Y3118069 |
5-Amino-2-bromo-4-fluorobenzonitrile |
1613386-27-8 |
98% |
| Y3267253 |
TLR9-IN-1 |
2226366-86-3 |
99% |
| Y3118075 |
SCFSkp2-IN-2 |
1375060-02-8 |
98% |
| Y3289306 |
Glucocorticoid receptor agonist-2 |
2166378-92-1 |
99% |
| Y3293347 |
PCAF-IN-2 |
56173-05-8 |
98% |
| Y3296803 |
1-(Iodomethyl)-4-(trifluoromethyl)-2-oxabicyclo[2.1.1]hexane |
2287288-10-0 |
95% |
| Y3296733 |
Z-Arg-SBzl |
88253-86-5 |
96% |
| Y3295587 |
GLUT4-IN-2 |
2454113-83-6 |
99% |
| Y3318423 |
3-Fluoro-5-iodo-2-methoxypyridine |
1806542-88-0 |
95% |
| Y3293144 |
STING agonist-20 |
2591300-72-8 |
95% |
| Y3271627 |
4-(Difluoromethyl)-1-(iodomethyl)-2-oxabicyclo[2.1.1]hexane |
2639420-20-3 |
95% |
| Y3287962 |
G0-C14 |
1510653-27-6 |
98% |
| Y3310054 |
2-(2-Isopropoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
1266379-28-5 |
95% |
| Y3293505 |
AK-778-XXMU |
1227045-76-2 |
98% |
| Y3269735 |
(4-(Thiazol-2-ylcarbamoyl)piperidine-1-carbonyl)-L-leucine |
1814897-92-1 |
99% |
| Y3290692 |
Pefloxacin-d3 |
2733455-58-6 |
99% |
| Y3267670 |
(1-(Tetrahydro-2H-pyran-2-yl)-1H-imidazol-2-yl)methanol |
2158677-73-5 |
98% |
| Y3269857 |
5-Methyltetrahydrofolic acid-13C5 |
1207282-74-3 |
98% |
| Y3287504 |
Djalonensone-d3 |
2468774-90-3 |
95% |
| Y3295364 |
IDH1 Inhibitor 7-d2 |
2135309-51-0 |
99% |
| Y3309137 |
MR 409 |
1445155-39-4 |
99% |
| Y3293471 |
Mevalonic acid-13C,d3 sodium |
2747918-57-4 |
99% |
| Y3287652 |
Bisphenol Z-d6 |
2733972-12-6 |
95% |
| Y3297743 |
Mal-PEG2-Val-Cit-PABA |
1662687-83-3 |
98% |
| Y3105036 |
Deshydroxyethoxy Ticagrelor-d7 |
2734919-83-4 |
95% |
| Y3104859 |
Glucocorticoid receptor agonist-1 phosphate Gly-Glu-Br |
2344809-82-9 |
98% |
| Y3105039 |
Lidocaine-d6 hydrochloride |
2517378-96-8 |
95% |
| Y3118071 |
Sodium 5-chloropyridine-2-sulfinate |
2098851-54-6 |
95% |
| Y3287455 |
Cefoperazone-d5 |
2410425-70-4 |
98% |
| Y3286360 |
2,4-Dihydroxybenzophenone-13C6 |
2731164-01-3 |
95% |
| Y3288320 |
Fura Red AM |
218280-33-2 |
91% |
| Y3295414 |
tert-Butyl 1'-(4-methoxybenzyl)-2'-oxospiro[azetidine-3,3'-indoline]-1-carboxylate |
1603067-25-9 |
95% |
| Y3118062 |
Antimicrobial agent-21 |
724746-07-0 |
98% |
| Y3293109 |
A1AT modulator 2 |
2555004-05-0 |
98% |
| Y3271794 |
AMT-NHS |
2925268-86-4 |
98.55% |
| Y3268498 |
PD-L1-IN-1 |
2767424-13-3 |
99.53% |
| Y3306731 |
1-(1-(2,2,2-Trifluoroethyl)piperidin-4-yl)ethan-1-one |
1344108-31-1 |
95% |
| Y3297361 |
QR-0217 |
1027786-12-4 |
98% |
| Y3287023 |
TMX-201 |
1149339-78-5 |
95% |
| Y3269612 |
SHP2 protein degrader-2 |
2740582-16-3 |
99.76% |
| Y3287018 |
PARP1-IN-11 |
2482484-87-5 |
98% |
| Y3311301 |
DY-46-2 |
1105110-83-5 |
99% |
| Y3306483 |
a7 Nicotinic receptor agonist-1 |
220100-05-0 |
99% |
| Y3272579 |
M3913 |
2379783-62-5 |
99.54% |
| Y3113809 |
ANO1-IN-1 |
407587-01-3 |
98% |
| Y3260623 |
eIF4A3-IN-18 |
1402931-84-3 |
98% |
| Y3266837 |
BCAT-IN-1 |
1875078-61-7 |
96.40% |
| Y3113810 |
TGFß1-IN-1 |
2348795-14-0 |
98% |
| Y3289290 |
NLRP3-IN-18 |
2769040-06-2 |
98% |
| Y3266390 |
Berberine ursodeoxycholate |
1868138-66-2 |
98.75% |
| Y3310776 |
DfTat |
2035480-78-3 |
99% |
| Y3264764 |
(r)-2-Amino-2-(2-chloro-3-methylphenyl)ethan-1-ol |
1213919-26-6 |
95% |
| Y3308433 |
FOXO4-DRI |
2460055-10-9 |
99% |
| Y3309923 |
Amabiloside |
40555-38-2 |
98% |
| Y3270803 |
KS100 |
2408477-54-1 |
99% |
| Y3271247 |
AAA-10 |
2758171-70-7 |
98.0% |
| Y3268623 |
MY33-3 |
2204280-41-9 |
98.84% |
| Y3114294 |
5-Amino-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1H-1,2,3-triazole-4-carboxylic acid |
1259057-93-6 |
95% |
| Y3294763 |
I-152 |
311343-11-0 |
98% |
| Y3312624 |
(r)-2-Amino-2-(3,5-dimethylphenyl)ethan-1-ol |
1213888-73-3 |
97% |
| Y3292903 |
Fuzapladib sodium |
141284-73-3 |
99% |
| Y3268557 |
IGUANA-1 |
2756014-25-0 |
98% |
| Y3291227 |
Feniralstat |
2166320-76-7 |
99% |
| Y3266667 |
KWCN-41 |
2913223-17-1 |
99% |
| Y3266689 |
20S Proteasome activator 1 |
2761578-18-9 |
99% |